I noticed after they announced their participation in JPM’s Biotech 2020 that volume increased by approximately a million shares. Shlingel is correct - this conference is different and Misiu you correctly pointed out that the head of our Pharma partner was prior JPM and as Evil pointed out we’re talking Oncology. Would be home run if they replicate that conference call with Dr NP, Dr Jonah Sacha and Dr Patterson, and the Dr in SF who is injecting patients. Bring them all in - it’s that level of conference.